52 results on '"Köbel, Martin"'
Search Results
2. The association between body mass index and molecular subtypes in endometrial carcinoma
3. Spatial Cancer-Immune Phenotypes Predict Shorter Recurrence-Free Survival in the No Specific Molecular Profile Molecular Subtype of Endometrial Carcinoma
4. Dedifferentiated and Undifferentiated Ovarian Carcinoma: An Aggressive and Molecularly Distinct Ovarian Tumor Characterized by Frequent SWI/SNF Complex Inactivation
5. Establishment and validation of preclinical models of SMARCA4-inactivated and ARID1A/ARID1B co-inactivated dedifferentiated endometrial carcinoma
6. Molecular analysis suggests oligoclonality and metastasis of endometriosis lesions across anatomically defined subtypes
7. Prognostic significance of T cells, PD-L1 immune checkpoint and tumour associated macrophages in clear cell carcinoma of the ovary
8. Targeted RNA expression profiling identifies high-grade endometrial stromal sarcoma as a clinically relevant molecular subtype of uterine sarcoma
9. Embryonic protein NODAL regulates the breast tumor microenvironment by reprogramming cancer-derived secretomes
10. Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses
11. Malignancy is in the eye of the beholder: Pathologic diagnosis of challenging follicular neoplasms in the era of noninvasive follicular thyroid neoplasms with papillary-like nuclear features and immunohistochemical and molecular adjuncts
12. Low junctional adhesion molecule-A expression is associated with an epithelial to mesenchymal transition and poorer outcomes in high-grade serous carcinoma of uterine adnexa
13. PIK3CA mutation and CNV status and post-chemoradiotherapy survival in patients with cervical cancer
14. Low-grade serous carcinoma (LGSC): A Canadian multicenter review of practice patterns and patient outcomes
15. Hormone receptor expression and outcomes in low-grade serous ovarian carcinoma
16. Therapeutic options for mucinous ovarian carcinoma
17. Newly recognized non-adenomatous lesions associated with enteric carcinomas in inflammatory bowel disease – Report of six rare and unique cases
18. A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases
19. FIGO Stage Is the Strongest Prognostic Factor in Adenocarcinoma of the Uterine Cervix
20. Histotype classification of ovarian carcinoma: A comparison of approaches
21. Expression of PD-L1 and presence of CD8-positive T cells in pre-treatment specimens of locally advanced cervical cancer
22. Concurrent ARID1A and ARID1B inactivation in endometrial and ovarian dedifferentiated carcinomas
23. Tea, coffee, and caffeinated beverage consumption and risk of epithelial ovarian cancers
24. Molecular classification of endometrial carcinoma on diagnostic specimens is highly concordant with final hysterectomy: Earlier prognostic information to guide treatment
25. Progesterone receptor expression is associated with longer overall survival within high-grade histotypes of endometrial carcinoma: A Canadian high risk endometrial cancer consortium (CHREC) study
26. Treatment related outcomes in high-risk endometrial carcinoma: Canadian high risk endometrial cancer consortium (CHREC)
27. Loss of switch/sucrose non-fermenting complex protein expression is associated with dedifferentiation in endometrial carcinomas
28. Adult lifetime alcohol consumption and invasive epithelial ovarian cancer risk in a population-based case–control study
29. Smoking may modify the association between neoadjuvant chemotherapy and survival from ovarian cancer
30. Canadian high risk endometrial cancer (CHREC) consortium: Analyzing the clinical behavior of high risk endometrial cancers
31. Clinicopathological analysis of endometrial carcinomas harboring somatic POLE exonuclease domain mutations
32. Corrigendum to “Grade and Estrogen Receptor Expression Identify a Subset of No Specific Molecular Profile Endometrial Carcinomas at a Very Low Risk of Disease-Specific Death”: [Modern Pathology 36 (2023) 100085]
33. POLE exonuclease domain mutation predicts long progression-free survival in grade 3 endometrioid carcinoma of the endometrium
34. PIK3CA missense mutation is associated with unfavorable outcome in grade 3 endometrioid carcinoma but not in serous endometrial carcinoma
35. Reproducibility of histological cell type in high-grade endometrial carcinoma
36. MMR deficiency is common in high-grade endometrioid carcinomas and is associated with an unfavorable outcome
37. The diagnostic utility of TP53 and CDKN2A to distinguish ovarian high-grade serous carcinoma from low-grade serous ovarian tumors
38. Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study
39. PIK3CA mutational status and overall survival in patients with cervical cancer treated with radical chemoradiotherapy
40. Quantification of ER/PR expression in ovarian low-grade serous carcinoma
41. BRCA1 and BRCA2 mutations correlate with TP53 abnormalities and presence of immune cell infiltrates in ovarian high-grade serous carcinoma
42. Mucinous carcinomas of the ovary and colorectum: different organ, same dilemma
43. Clear cell carcinoma of the ovary: A report from the first Ovarian Clear Cell Symposium, June 24th, 2010
44. Calculator for ovarian carcinoma subtype prediction
45. Molecular Pathology of Ovarian Carcinomas
46. Implications for management of ovarian cancer in a transgender man: Impact of androgens and androgen receptor status
47. IGF2BP3 (IMP3) expression is a marker of unfavorable prognosis in ovarian carcinoma of clear cell subtype
48. Ezrin expression is related to poor prognosis in FIGO stage I endometrioid carcinomas
49. Protracted clinical course of an AFF1 fusion positive uterine smooth muscle tumor causing diagnostic confusion over a course of 15 years
50. The MOCOG study: Learning from extraordinary responders to improve treatment outcomes for women with ovarian cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.